pharma news today glp-1 obesity drug Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1s and the Unintended Consequences
Description
Acta Pharmaceutica Sinica B 11 (8)
5 min read Coach Trent : Jul 1, 2025 9:00:40 AM Key Highlights Fueled by media attention, celebrity endorsements, and direct-to-consumer marketing, these drugs have quickly gained mainstream awareness in the health and wellness landscape
2019 Update to: management of hyperglycemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care
The request comes after a safety review that analyzed nearly 100 placebo-controlled clinical trials with over 106,000 patients and found no increased risk of suicidal thoughts or behavior related to GLP-1 use
AM: I love that
